The detection of PCA3 in urine is a more specific marker for prostate cancer diagnosis than the commonly used factor, prostate specific antigen (PSA), and has been widely applied in the clinic (Hessels et al., 2003; Tinzl et al., 2004). The gene discussed is KLK3; the disease is prostate carcinoma.